Company intelligence / Profile preview

Zhongyuan Bank

Hong Kong, China

Ownership: Private
Development stage: Other

Overview

Zhong Yuan Bio-Technology Holdings Ltd. is a biotech company focused on neurological disease research and development. Their work includes small molecule drugs, plant-derived nervonic acid health supplements, and early detection kits for brain diseases, targeting indications such as cognitive impairment, brain atrophy, and encephalopathies.

Therapeutic areas: Neurology
Modalities: Small molecule drugsHealth supplements
Industry: Biotech

Beyond the preview

Go deeper on Zhongyuan Bank.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongyuan Bank.

Explore the full profile